MIND and Tech Ltd. is an innovative technology company developing novel nanoparticle-based tools for Medical Imaging and Nano Diagnostics. Our company provides a cost-effective, simple, direct yet sensitive platform for early neurodegenerative diseases detection and diagnostics. Benefiting from our designed fluorophore, it is the first detection assay capable of measuring the subtle changes in the expression profile of disease associated biomarkers.
Over 50 millions of people in the world are living with dementia, as more people tend to live into the old age, the patient number is expected to triple by 2050. Alzheimer’s disease (AD) is the most prevalence cause of dementia and accounts for two thirds of the cases. Until now, there is no treatment available to halt or reverse the underlying pathology of AD, only early diagnosis and treatment are the best chance to ameliorate the symptoms of this devastating disease.
To provide a solution for early Alzheimer’s disease diagnosis by developing an Affordable, Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free and Deliverable (ASSURED) point-of-care tool for population-wide screening of Alzheimer’s disease and a dual-model contrast agent for AD-associated biomarker imaging for Alzheimer’s disease diagnosis.